Hallensleben Nora D, Umans Devica S, Bouwense Stefan Aw, Verdonk Robert C, Romkens Tessa Eh, Witteman Ben J, Schwartz Matthijs P, Spanier Marcel B, Laheij Robert, van Santvoort Hjalmar C, Besselink Marc G, van Hooft Jeanin E, Bruno Marco J
Department of Gastroenterology, Erasmus MC University Medical Centre, Rotterdam, the Netherlands.
Department of Research and Development, St. Antonius Hospital, Nieuwegein, the Netherlands.
United European Gastroenterol J. 2020 Apr;8(3):340-350. doi: 10.1177/2050640619890462. Epub 2019 Nov 14.
After standard diagnostic work-up, the aetiology of acute pancreatitis remains unknown in 16-27% of cases, a condition referred to as idiopathic acute pancreatitis (IAP). Determining the aetiology of pancreatitis is essential, as it may direct treatment in the acute phase and guides interventions to prevent recurrent pancreatitis.
Between 2008 and 2015, patients with acute pancreatitis were registered prospectively in 19 Dutch hospitals. Patients who had a negative initial diagnostic work-up with regard to the underlying aetiology of their pancreatitis were labelled 'presumed' IAP. The aim of this study was to assess the use of diagnostic modalities and their yield to establish an aetiology in 'presumed' IAP, and to assess recurrence rates both with and without treatment.
Out of the 1632 registered patients, 191 patients had a first episode of 'presumed' IAP, of whom 176 (92%) underwent additional diagnostic testing: CT ( = 124, diagnostic yield 8%), EUS ( = 62, yield 35%), MRI/MRCP ( = 56, yield 33%), repeat ultrasound ( = 97, yield 21%), IgG4 (n = 54, yield 9%) and ERCP ( = 15, yield 47%). In 64 of 176 patients (36%) an aetiological diagnosis was established, mostly biliary ( = 39). In 13 out of 176 of patients (7%) a neoplasm was diagnosed. If additional diagnostic workup revealed an aetiology, the recurrence rate was lower in the treated patients than in the patients without a definite aetiology (15% versus 43%, = 0.014).
Additional diagnostic testing revealed an aetiology in one-third of 'presumed' IAP patients. The aetiology found was mostly biliary, but occasionally neoplasms were found. Identification of an aetiology with subsequent treatment reduced the rate of recurrence.
在进行标准诊断检查后,16% - 27%的急性胰腺炎病例病因仍不明,这种情况被称为特发性急性胰腺炎(IAP)。确定胰腺炎的病因至关重要,因为它可能指导急性期的治疗,并指导预防复发性胰腺炎的干预措施。
2008年至2015年间,荷兰19家医院对急性胰腺炎患者进行了前瞻性登记。那些胰腺炎潜在病因的初始诊断检查结果为阴性的患者被标记为“疑似”IAP。本研究的目的是评估诊断方法的使用及其在“疑似”IAP中确定病因的检出率,并评估治疗和未治疗患者的复发率。
在1632例登记患者中,191例患者首次发作“疑似”IAP,其中176例(92%)接受了额外的诊断检查:CT(n = 124,诊断检出率8%)、内镜超声(EUS,n = 62,检出率35%)、磁共振成像/磁共振胰胆管造影(MRI/MRCP,n = 56,检出率33%)、重复超声检查(n = 97,检出率21%)、免疫球蛋白G4(IgG4,n = 54,检出率9%)和内镜逆行胰胆管造影(ERCP,n = 15,检出率47%)。176例患者中有64例(36%)确诊病因,大多数为胆源性(n = 39)。176例患者中有13例(7%)诊断为肿瘤。如果额外的诊断检查发现了病因,接受治疗的患者复发率低于未明确病因的患者(15%对43%,P = 0.014)。
额外的诊断检查在三分之一的“疑似”IAP患者中发现了病因。发现的病因大多为胆源性,但偶尔也会发现肿瘤。确定病因并随后进行治疗可降低复发率。